Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis
The administration and prescribing of buprenorphine in the ED is heavily influenced by the presence of opioid withdrawal. Disparities disadvantage female patients and racial minorities. Some racial disparities, particularly among Black patients, are not evident when solely considering encounters involving opioid withdrawal. System-level interventions are needed to address disparities and improve the equitable uptake of ED-initiated buprenorphine.
Authors
- Natalie Parde (ORCID: https://orcid.org/0000-0003-0072-7499)
- Gail D’Onofrio (ORCID: https://orcid.org/0000-0002-3833-1871)
- Niranjan S. Karnik (ORCID: https://orcid.org/0000-0001-7650-3008)
- Neeraj Chhabra (ORCID: https://orcid.org/0000-0002-0945-1233)
- Joseph M. Bianco (ORCID: https://orcid.org/0000-0002-8598-0604)
- Richard A. Taylor (ORCID: https://orcid.org/0000-0002-9082-6644)
- Dale Smith
- Nicole Hsing‐Smith
Institutions
- Illinois College (US)
- Yale University (US)
- University of Illinois Chicago (US)
Publication Details
- Journal
- Academic Emergency Medicine
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1111/acem.70035
- Citations
- 4
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.51
Funders
- National Institute on Drug Abuse